Eczema Free Forever™

Gene therapy trial for blistering skin condition advancing to next phase

FCX-007 could be the first major medical advance for recessive dystrophic epidermolysis bullosa, or RDEB, in decades.
Dermatology Times – Dermatology

Eczema Free Forever™